Performance of a questionnaire for screening people with undiagnosed diabetes;Utilidad de un cuestionario en la detección de individuos con riesgo de diabetes mellitus asintomática

Revista de Investigacion Clinica

Volumn 51, Issue 3, 1999, Pages 175-182

  Domínguez Reyes, Carlos A ^a   Serrano Carrillo, Andrea S ^a   Soriano, Isis Lozano ^a   López Soto, José J ^b  

^a Hospital de Especialidades Miguel Hidalgo   (Mexico)

^b Asociación Mexicana de Diabetes en la Ciudad de México   (Mexico)

Author keywords

Diabetes mellitus; Mexicans; Risk factors; Screening test

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; LIFESTYLE; MALE; MASS SCREENING; METHODOLOGY; MEXICO; QUESTIONNAIRE; RISK FACTOR;

ADULT; DIABETES MELLITUS; FEMALE; HUMANS; LIFE STYLE; MALE; MASS SCREENING; MEXICO; QUESTIONNAIRES; RISK FACTORS;

EID: 0005447926     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. González-Villalpando C, Stern MP, Villalpando E, Hazuda H, Haffner SM, Lisci E. Prevalencia de diabetes e intolerancia a la glucosa en una población urbana de nivel económico bajo. Rev Invest Clin 1992; 44: 321-8.
2. Secretaría de Salud México. Encuesta Nacional de Enfermedades Crónicas 1993.
3. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-77.
4. American Diabetes Association. Diabetes 1996 Vital Statistics. Alexandria, VA: American Diabetes Association, 1996.
5. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
6. Klein R, Klein BEK, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 1993; 16: 1325-30.
7. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. Diabetes Care 1997; 20:163-9.
8. Singh BM, Prescott JJW, Guy R, Walford S, Murphy M, Wise PH. Effect of advertising on awareness of symptoms of diabetes among the general public: The British Diabetic Association Study. BMJ 1994; 308: 632-6.
9. Home PD. Diagnosing the undiagnosed with diabetes: Professional alertness remains the most efficient approach. BMJ 1994; 308: 611-2.
10. Forrest RD, Jackson CA, Yudkin JS. Screening for diabetes mellitus in general practice using a reflectance meter system. The Isllington Diabetes Survey. Diabetes Res 1987; 6: 119-22
11. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995; 18: 382-7.
12. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes 1979; 28: 1039-57.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
14. Singer DE, Jeffrey HS, Samet H, Coley CM, Nathan DM. Screening for diabetes. Ann Intern Med 1988; 109: 639-49.
15. Knowler WC. Screening for diabetes: Opportunities for detection, treatment, and prevention. Diabetes Care 1994; 17: 445-50.
16. American Diabetes Association. American diabetes alert. Diabetes Forecast 1993; 46: 54-5.
17. Burden ML, Burden AC. The American Diabetes Association screening questionnaire for diabetes. Is it worthwhile in the UK? (Letter). Diabetes Care 1994; 17:97.
18. Díaz-Campos R, De la garza O, Cortés J, Forsbach G, Sánchez V, Palmeros CI. Detección de diabetes mellitus no insulinodependiente en adultos asintomáticos. Rev Invest Clin 1993; 45: 553-7.
19. Posadas-Romero C, Yamamoto-Kimura L, Lerman-Garber I, Zamora-González J, Fajardo-Gutierrez A et al. The prevalence of NIDDM and associated coronary risk factors in Mexico City. Diabetes Care 1994; 12: 1441-8.
20. Quibrera R, Hernández HG, Aradillas C, González S, Calles-Escandón J. Prevalencia de diabetes, intolerancia a la glucosa, hiperlipidemia y factores de riesgo en función de nivel socioeconómico. Rev Invest Clin 1994; 46: 25-36.
21. Engelgau MM, Thompson TJ, Smith PJ, Herman WH, Aubert RE et al. Screening for diabetes mellitus in adults: the utility of random capillary blood glucose measurements. Diabetes Care 1995; 18: 463-6.
22. Bortheiry AI, Malerbi DA, Franco LJ. The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT. Diabetes Care. 1994; 17:1269-72.
23. American Diabetes Association. Position statement: Screening diabetes. Diabetes Care 1996; 19 (suppl 1): S5-S6.
24. Newman WP, Nelson R, Scheer K. Community screening for diabetes: Low detection rate in a low-risk population. Diabetes Care 1994; 17:363-5.
25. Harris MI. Undiagnosed NIDDM, clinical, and public health issues. Diabetes Care 1993; 16: 642-52.
26. Cowie CC, Harris MI, Eberhardt MS. Frequency and determinants of screening for diabetes in the U.S. Diabetes Care 1994; 17: 1158-63.
27. Ruige JB, Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20: 491-6.
28. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research: getting better but still not good. JAMA 1995; 274:645-51.